Qureight
Pioneering data curation to solve complex diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
* | $8.5m | Series A | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | 243 % | 13 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Qureight is a pioneering data curation company focused on solving complex diseases by managing, curating, and post-processing clinical data in one place. The company collaborates with world-leading hospitals, academic institutions, and global biopharma companies to maximize the value of curated data. Qureight's platform allows users to upload imaging and biomarker data, annotate clinical information into structured, task-ready data, and analyze complex data using proprietary tools. The platform also integrates complex data with novel AI software solutions, ensuring ethical data access and security. Qureight serves clients in the healthcare and biopharma sectors, operating in the clinical data management market. The business model is based on providing a comprehensive data management platform that ensures data is curated to the highest standards, maintaining ownership and full control for collaborative analytics. The company generates revenue through subscriptions and partnerships with healthcare institutions and biopharma companies.
Keywords: data curation, clinical data, AI solutions, healthcare, biopharma, imaging data, biomarker data, data annotation, data security, collaborative analytics.